|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Research and development | |||||
| Restructuring charges | |||||
| Impairment charges | |||||
| Acquisitions and disposals costs | |||||
| Disposal related costs | |||||
| Other charges | |||||
| Other (costs) / income | |||||
| Loss on held-for-sale asset group | |||||
| Operating income | |||||
| Net interest expense | |||||
| Defined benefit pension credit / (charge) | |||||
| Income / (loss) before income taxes | |||||
| (Provision) / credit for income taxes | |||||
| Net income / (loss) from continuing operations | |||||
| Net gain on disposition of discontinued operations | |||||
| (Loss) / income from discontinued operations, net of tax | |||||
| Net income / (loss) | |||||
| Earnings / (loss) per share | |||||
| Basic earnings / (loss) from continuing operations (in USD per share) | |||||
| Basic from discontinued operations (in USD per share) | |||||
| Basic earnings / (loss) per ordinary share (in USD per share) | |||||
| Diluted from continuing operations (in USD per share) | |||||
| Diluted from discontinued operations (in USD per share) | |||||
| Diluted earnings / (loss) per ordinary share (in USD per share) | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...